Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-16,900
Closed -$239K 1013
2020
Q3
$239K Buy
16,900
+8,400
+99% +$97.9K ﹤0.01% 924
2020
Q2
$94K Buy
+8,500
New +$77.4K ﹤0.01% 983
2019
Q3
Sell
-15,080
Closed -$123K 1157
2019
Q2
$123K Sell
15,080
-12,500
-45% -$113K ﹤0.01% 1007
2019
Q1
$288K Sell
27,580
-2,500
-8% -$23.7K ﹤0.01% 971
2018
Q4
$198K Sell
30,080
-42,300
-58% -$307K ﹤0.01% 979
2018
Q3
$586K Buy
72,380
+6,241
+9% +$78.8K ﹤0.01% 968
2018
Q2
$999K Sell
66,139
-50,446
-43% -$543K 0.01% 941
2018
Q1
$927K Buy
116,585
+21,411
+22% +$142K 0.01% 982
2017
Q4
$500K Buy
+95,174
New +$351K ﹤0.01% 1037

Other funds holding EGAN

Royce & Associates's EGAN Position: Q4 2020 in Review

Royce & Associates sold out of eGain (EGAN) in Q4 2020, closing a stake of 16,900 shares — an estimated $239K sold.

Royce & Associates first reported a position in EGAN in Q4 2017 and held it in 9 quarters. The position peaked at $999K in Q2 2018. 112 funds tracked by Wall St. Rank hold EGAN as of Q4 2020.

  • Royce & Associates reported no remaining eGain position as of Q4 2020 after selling out during the quarter.
  • Royce & Associates sold 16,900 eGain shares in Q4 2020, an estimated $239K.
  • Royce & Associates first reported a position in eGain in Q4 2017 and held it in 9 quarters.
  • Royce & Associates's eGain position peaked at $999K in Q2 2018.
  • 112 funds tracked by Wall St. Rank held eGain as of Q4 2020.

Based on Royce & Associates's 13F filing for Q4 2020, filed 8 Feb 2021.